We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$29.2M
Cap. Flow
+$27.6M
Cap. Flow %
13.39%
Top 10 Hldgs %
88.47%
Holding
181
New
37
Increased
23
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Real Estate 17.29%
2 Healthcare 5.02%
3 Technology 2.17%
4 Industrials 1.56%
5 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAP
126
DELISTED
Adaptimmune Therapeutics
ADAP
$34K 0.02%
4,200
+2,400
+133% +$21K
ADCT icon
127
ADC Therapeutics
ADCT
$146M
$33K 0.02%
+1,000
New +$43.3K
BIO icon
128
Bio-Rad Laboratories Class A
BIO
$8.42B
$33K 0.02%
64
WBA
129
DELISTED
Walgreens Boots Alliance
WBA
$32K 0.02%
900
+600
+200% +$23.5K
CHRS icon
130
Coherus Oncology
CHRS
$217M
$29K 0.01%
1,600
-400
-20% -$7.44K
NBIX icon
131
Neurocrine Biosciences
NBIX
$17.7B
$29K 0.01%
300
+75
+33% +$8.68K
DGX icon
132
Quest Diagnostics
DGX
$25.1B
$27K 0.01%
235
-75
-24% -$8.86K
BFK
133
DELISTED
BlackRock Municipal Income Trust
BFK
$26K 0.01%
1,900
SHYD icon
134
VanEck Short High Yield Muni ETF
SHYD
$447M
$26K 0.01%
1,050
MYJ
135
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$26K 0.01%
+1,900
New +$26.8K
MUS
136
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$26K 0.01%
2,050
SRPT icon
137
Sarepta Therapeutics
SRPT
$1.66B
$25K 0.01%
+175
New +$26.6K
GWPH
138
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$24K 0.01%
250
-50
-17% -$5.75K
MYOK
139
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$24K 0.01%
+175
New +$18.6K
BLE
140
DELISTED
BlackRock Municipal Income Trust II
BLE
$22K 0.01%
1,490
RETA
141
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$22K 0.01%
+225
New +$28.1K
BTA
142
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$21K 0.01%
1,750
HYD icon
143
VanEck High Yield Muni ETF
HYD
$4.44B
$21K 0.01%
350
HYMB icon
144
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.07B
$21K 0.01%
740
INSM icon
145
Insmed
INSM
$23.2B
$21K 0.01%
653
+353
+118% +$10.1K
SYRE icon
146
Spyre Therapeutics
SYRE
$8.87B
$21K 0.01%
+120
New +$22.2K
FATE icon
147
Fate Therapeutics
FATE
$281M
$20K 0.01%
500
IDYA icon
148
IDEAYA Biosciences
IDYA
$3.41B
$19K 0.01%
1,500
NMCO icon
149
Nuveen Municipal Credit Opportunities Fund
NMCO
$579M
$14K 0.01%
+1,100
New +$14.1K
UNH icon
150
UnitedHealth
UNH
$382B
$14K 0.01%
45

Similar funds

AlphaCentric Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, AlphaCentric Advisors held 181 positions worth $207M, up 16% from $177M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

AlphaCentric Advisors deployed $27.6M of net new capital in Q3 2020, opening 37 new positions and adding to 23 existing holdings. Its largest new stake was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $2.55M trimmed.

  • AlphaCentric Advisors's largest Q3 2020 buy was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2020, an estimated $27.6M increase.
  • AlphaCentric Advisors's biggest Q3 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.55M.
  • AlphaCentric Advisors fully exited Nano Dimension in Q3 2020, selling an estimated $330K.
  • AlphaCentric Advisors's ten largest holdings make up 88% of its $207M portfolio in Q3 2020.
  • AlphaCentric Advisors opened 37 new positions and closed 16 in Q3 2020.
  • AlphaCentric Advisors's portfolio value rose 16% quarter-over-quarter to $207M.

Based on AlphaCentric Advisors's 13F filing for Q3 2020, filed 11 Mar 2022.